Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial.
[en] BACKGROUND: Our aims were to compare coronary artery bypass grafting (CABG) and stenting for the treatment of diabetic patients with multivessel coronary disease enrolled in the Arterial Revascularization Therapy Study (ARTS) trial and to determine the costs of these 2 treatment strategies. METHODS AND RESULTS: Patients (n=1205) were randomly assigned to stent implantation (n=600; diabetic, 112) or CABG (n=605; diabetic, 96). Costs per patient were calculated as the product of each patient's use of resources and the corresponding unit costs. Baseline characteristics were similar between the groups. At 1 year, diabetic patients treated with stenting had the lowest event-free survival rate (63.4%) because of a higher incidence of repeat revascularization compared with both diabetic patients treated with CABG (84.4%, P<0.001) and nondiabetic patients treated with stents (76.2%, P=0.04). Conversely, diabetic and nondiabetic patients experienced similar 1-year event-free survival rates when treated with CABG (84.4% and 88.4%). The total 1-year costs for stenting and CABG in diabetic patients were $12 855 and $16 585 (P<0.001) and in the nondiabetic groups, $10 164 for stenting and $13 082 for surgery. CONCLUSIONS: Multivessel diabetic patients treated with stenting had a worse 1-year outcome than patients assigned to CABG or nondiabetics treated with stenting. The strategy of stenting was less costly than CABG, however, regardless of diabetic status.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Abizaid, A.
Costa, M. A.
Centemero, M.
Abizaid, A. S.
Legrand, Victor ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie
Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial.
Publication date :
2001
Journal title :
Circulation
ISSN :
0009-7322
eISSN :
1524-4539
Publisher :
Lippincott Williams & Wilkins, United States - Maryland
Carrozza J.P. Jr., Kuntz R.E., Fishman R.F. (1993) Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 118:344-349.
Stein B., Weintraub W.S., Gebhart S.P. (1995) Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 91:979-989.
Kip K.E., Faxon D.P., Detre K.M. (1996) Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 94:1818-1825.
Abizaid A., Kornowski R., Mintz G.S. (1998) The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32:584-589.
Elezi S., Kastrati A., Pache J. (1998) Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32:1866-1873.
Van Belle E., Bauters C., Hubert E. (1997) Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96:1454-1460.
(1997) Influence of diabetes on 5-year mortality morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI). Circulation 96:1761-1769.
King S.B.I., Kosinski A.S., Guyton R.A. (2000) Eight year mortality in the Emory Angioplasty vs. Surgery Trial (EAST). J Am Coll Cardiol 35:1116-1121.
(1996) Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med , The Bypass Angioplasty Revascularization Investigation (BARI) Investigators; 335:217-225.
King III S.B., Lembo N.J., Weintraub W.S. (1994) A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 331:1044-1050.
Serruys P.W., De Jaegere P., Kiemeneij F. (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med , Benestent Study Group; 331:489-495.
Fischman D.L., Leon M.B., Baim D.S. (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med , Stent Restenosis Study Investigators; 331:496-501.
Versaci F., Gaspardone A., Tomai F. (1997) A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 336:817-822.
Serruys P.W., Van Hout B., Bonnier H. (1998) Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 352:673-681.
Erbel R., Haude M., Hopp H.W. (1998) Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. N Engl J Med , Restenosis Stent Study Group; 339:1672-1678.
Green G.E. (1989) Use of internal thoracic artery for coronary artery grafting. Circulation 79(SUPPL. I).
Bergsma T.M., Grandjean J.G., Voors A.A. (1998) Low recurrence of angina pectoris after coronary artery bypass graft surgery with bilateral internal thoracic and right gastroepiploic arteries. Circulation 97:2402-2405.
Serruys P.W., Unger F., Sousa J.E. (2001) Randomized comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344:1117-1124.
Edlavitch S.A., Crow R., Burke G.L. (1991) Secular trends in Q wave and non-Q wave acute myocardial infarction. The Minnesota Heart Survey. Circulation 83:492-503.
Van Hout B.A., Van der Woude T., De Jaegere P.P. (1996) Cost effectiveness of stent implantation versus PTCA: The BENESTENT experience. Semin Interv Cardiol 1:263-268.
Greenland S., Robins J.M. (1985) Estimation of a common effect parameter from sparse follow-up data. Biometrics 41:55-68.
Borst C., Grundeman P.F. (1999) Minimally invasive coronary artery bypass grafting: An experimental perspective. Circulation 99:1400-1403.
John R., Choudhri A.F., Weinberg A.D. (2000) Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg 69:30-35.
Rozenman Y., Sapoznikov D., Mosseri M. (1997) Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: A clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. J Am Coll Cardiol 30:1420-1425.
Kuntz R.E. (1999) Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: The diabetes-percutaneous transluminal coronary angioplasty dilemma. Circulation 99:847-851.
Rensing B.J., Hermans W.R., Vos J. (1993) Luminal narrowing after percutaneous transluminal coronary angioplasty: A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Circulation , Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group; 88:975-985.
Holmes D.R. Jr., Vlietstra R.E., Smith H.C. (1984) Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 53.
Hirshfeld J.W. Jr., Schwartz J.S., Jugo R. (1991) Restenosis after coronary angioplasty: A multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol , The M-HEART Investigators; 18:647-656.
Van Belle E., Abolmaali K., Bauters C. (1999) Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. J Am Coll Cardiol 34:476-485.
Kornowski R., Mintz G.S., Kent K.M. (1997) Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: A serial intravascular ultrasound study. Circulation 95:1366-1369.
Davi G., Catalano I., Averna M. (1990) Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 322:1769-1774.
Marso S.P., Lincoff A.M., Ellis S.G. (1999) Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy. Circulation 100:2477-2484.
Teirstein P.S., Massullo V., Jani S. (1998) A subgroup analysis of the Scripps Coronary Radiation to Inhibit Proliferation Poststenting Trial. Int J Radiat Oncol Biol Phys 42:1097-1104.
Sousa J.E., Costa M.A., Abizaid A. (2001) Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A QCA and three-dimensional IVUS study. Circulation 103:192-195.
Califf R.M. (1995) Restenosis: The cost to society. Am Heart J 130:680-684.
